Remission of hormone-refractory prostate cancer attributed to Essiac.
Essiac is a popular complementary and alternative medicine (CAM) that is utilized by many cancer patients in North America. Much anecdotal reporting exists about its cancer-fighting qualities, but so far no clinical trials have been preformed to validate those claims. We describe here the case of a 64-year-old man whose hormone-refractory prostate cancer responded well to Essiac tea.
Al-Sukhni
Wigdan
W
Division of Urology, The Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
Grunbaum
Ami
A
Fleshner
Neil
N
D006801:Humans; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D012074:Remission Induction
C111756:Essiac; D010936:Plant Extracts